2 completed, 2 unknown. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Unknown 2 |
| Phase 2 | 1 | Completed 1 |
Follow bromfenac: new trials by email Literature Review of bromfenac trials Research Report on bromfenac
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilocarpine, Brimonidine, Oxymetazoline (PBO) Compound to Control Presbyopia Symptoms Pilocarpine, brimonidine, oxymetazoline, hyaluronic acid, bromfenac (PBOHB) compound - Presbyopia | Phase 1 | Unknown | Optall Vision | 11 | 2021-08-14 | 2021-08-17 |
| Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients Compound Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac, Pilocarpine Hydrochloride, Brimonidine Tartrate - Presbyopia | Phase 1 | Unknown | Optall Vision | 11 | 2021-08-10 | 2021-08-19 |
| Safety and Tolerability of PRO-155 Ophthalmic Solution 0.09% in Healthy Volunteers. Bromfenac - Inflammation, Cataract | Phase 1 | Completed | Laboratorios Sophia S.A de C.V. | 35 | 2011-09-01 | 2019-10-16 |
| Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers ISV-303, DuraSite Vehicle, Xibromâ„¢ - Ocular Inflammation | Phase 1 / Phase 2 | Completed | Sun Pharmaceutical Industries Limited | 169 | 2010-08-01 | 2021-11-19 |
Presbyopia (2) · Cataract (1) · Inflammation (1)
Optall Vision (2) · Laboratorios Sophia S.A de C.V. (1) · Sun Pharmaceutical Industries Limited (1)
Mexico (3)
Cesar Alejandro S Galeana, MD (2) · Alfredo Lizarraga-Corona, MD (1) · Leopoldo M Baiza-Duran, MD (1)